263 related articles for article (PubMed ID: 7909157)
1. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
Udono H; Levey DL; Srivastava PK
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3077-81. PubMed ID: 7909157
[TBL] [Abstract][Full Text] [Related]
2. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
[TBL] [Abstract][Full Text] [Related]
3. Glucose-regulated protein 94/glycoprotein 96 elicits bystander activation of CD4+ T cell Th1 cytokine production in vivo.
Baker-LePain JC; Sarzotti M; Nicchitta CV
J Immunol; 2004 Apr; 172(7):4195-203. PubMed ID: 15034032
[TBL] [Abstract][Full Text] [Related]
4. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
5. Phylogenetic conservation of gp96-mediated antigen-specific cellular immunity: new evidence from adoptive cell transfer in xenopus.
Maniero GD; Robert J
Transplantation; 2004 Nov; 78(10):1415-21. PubMed ID: 15599304
[TBL] [Abstract][Full Text] [Related]
6. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection.
Yamazaki K; Nguyen T; Podack ER
J Immunol; 1999 Nov; 163(10):5178-82. PubMed ID: 10553037
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
Udono H; Srivastava PK
J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
[TBL] [Abstract][Full Text] [Related]
10. The dual nature of specific immunological activity of tumor-derived gp96 preparations.
Chandawarkar RY; Wagh MS; Srivastava PK
J Exp Med; 1999 May; 189(9):1437-42. PubMed ID: 10224283
[TBL] [Abstract][Full Text] [Related]
11. Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo.
Strbo N; Yamazaki K; Lee K; Rukavina D; Podack ER
Am J Reprod Immunol; 2002 Oct; 48(4):220-5. PubMed ID: 12516632
[TBL] [Abstract][Full Text] [Related]
12. Abrogation of tumor-inhibitory MRC-OX8+ (CD8+) effector T-cell generation in rats by selective depletion of neutrophils in vivo using a monoclonal antibody.
Tanaka E; Sendo F
Int J Cancer; 1993 Apr; 54(1):131-6. PubMed ID: 8478140
[TBL] [Abstract][Full Text] [Related]
13. Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis.
Chandawarkar RY; Wagh MS; Kovalchin JT; Srivastava P
Int Immunol; 2004 Apr; 16(4):615-24. PubMed ID: 15039392
[TBL] [Abstract][Full Text] [Related]
14. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96.
Strbo N; Oizumi S; Sotosek-Tokmadzic V; Podack ER
Immunity; 2003 Mar; 18(3):381-90. PubMed ID: 12648455
[TBL] [Abstract][Full Text] [Related]
15. Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.
Wang XY; Kazim L; Repasky EA; Subjeck JR
Int J Cancer; 2003 Jun; 105(2):226-31. PubMed ID: 12673684
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein-peptide complexes for use in vaccines.
Heike M; Noll B; Meyer zum Büschenfelde KH
J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice.
Sato K; Torimoto Y; Tamura Y; Shindo M; Shinzaki H; Hirai K; Kohgo Y
Blood; 2001 Sep; 98(6):1852-7. PubMed ID: 11535521
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor MHC class Ia-unrestricted CD8 T cell cytotoxicity elicited by the heat shock protein gp96.
Goyos A; Cohen N; Gantress J; Robert J
Eur J Immunol; 2004 Sep; 34(9):2449-58. PubMed ID: 15307177
[TBL] [Abstract][Full Text] [Related]
20. Generation of tumor-specific cytotoxic T lymphocytes and memory T cells by immunization with tumor-derived heat shock protein gp96.
Janetzki S; Blachere NE; Srivastava PK
J Immunother; 1998 Jul; 21(4):269-76. PubMed ID: 9672848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
